Efficacy and safety of bimekizumab in the treatment of psoriatic arthritis: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of bimekizumab in the treatment of psoriatic arthritis: a systematic review and meta-analysis

Published:2024-04-23 Issue: Volume: Page:1-9
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Su Qin-Yi¹²³,Yang Liu²³⁴,Cao Ting-Yu²³,Dang Hai-Ying²³,Han Zhuo-Chen²³,Cao Jia-Jing²³,Zhang He-Yi²³,Cheng Ting¹²³,Zhang Sheng-Xiao¹²³^ORCID,Huo Yue-Hong²³⁵

Affiliation:

1. Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

2. Ministry of Education, Key Laboratory of Cellular Physiology at Shanxi Medical University, Taiyuan, Prisma, China

3. Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, The Shanxi Medical University, Taiyuan, Shanxi, China

4. Department of Gynecology and Obstetrics, Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China

5. Department of Rheumatology, The Fifth People’s Hospital of Datong, Datong, Shanxi, China

Funder

National Science Foundation

the Natural Science Foundation of Shanxi Province

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2024.2343017

Reference30 articles.

1. Psoriatic Arthritis: Pathogenesis and Targeted Therapies

2. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

3. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

4. Quality of life in psoriatic arthritis

5. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era